Search research articles
Contact Us
Filters
Showing results (31-40 of 278) with videos related to
Page
of 28
Sort By:
Experimental Gerontology
|
July 4, 2012
Markov models of aging: theory and practice
David Steinsaltz, Gurjinder Mohan, Martin Kolb
Current Opinion in Pulmonary Medicine
|
July 23, 2013
Extracellular matrix microenvironment contributes actively to pulmonary fibrosis
Chiko Shimbori, Jack Gauldie, Martin Kolb
Respiratory Medicine
|
September 27, 2017
Therapeutic targets in idiopathic pulmonary fibrosis
Martin Kolb, Francesco Bonella, Lutz Wollin
Expert Review of Respiratory Medicine
|
October 22, 2013
New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research
Eva Baroke, Jack Gauldie, Martin Kolb
Thorax
|
April 13, 2016
Study the past to divine the future. Confucius' wisdom doesn't work for idiopathic pulmonary fibrosis
Martin Kolb, Gisli Jenkins, Luca Richeldi
Respirology (Carlton, Vic.)
|
November 14, 2009
How useful is traditional herbal medicine for pulmonary fibrosis?
Jiao Yang, Ye Cui, Martin Kolb
The European Respiratory Journal
|
August 18, 2018
Radiological diagnosis of interstitial lung disease: is it all about pattern recognition?
Simon L F Walsh, Martin Kolb
Chest
|
July 17, 2012
Angiogenesis in pulmonary fibrosis: too much or not enough?
Chandru Hanumegowda, Laszlo Farkas, Martin Kolb
The New England Journal of Medicine
|
May 12, 2021
Inhaled Treprostinil in Group 3 Pulmonary Hypertension
Mouhamad Nasser, Martin Kolb, Vincent Cottin
The European Respiratory Journal
|
April 5, 2020
Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis?
Robert P Dickson, Sergio Harari, Martin Kolb
Page
of 28
Search research articles
Search
Showing results (31-40 of 278) with videos related to
Sort By:
Page
of 28
Experimental Gerontology
|
July 4, 2012
Markov models of aging: theory and practice
David Steinsaltz, Gurjinder Mohan, Martin Kolb
Current Opinion in Pulmonary Medicine
|
July 23, 2013
Extracellular matrix microenvironment contributes actively to pulmonary fibrosis
Chiko Shimbori, Jack Gauldie, Martin Kolb
Respiratory Medicine
|
September 27, 2017
Therapeutic targets in idiopathic pulmonary fibrosis
Martin Kolb, Francesco Bonella, Lutz Wollin
Expert Review of Respiratory Medicine
|
October 22, 2013
New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research
Eva Baroke, Jack Gauldie, Martin Kolb
Thorax
|
April 13, 2016
Study the past to divine the future. Confucius' wisdom doesn't work for idiopathic pulmonary fibrosis
Martin Kolb, Gisli Jenkins, Luca Richeldi
Respirology (Carlton, Vic.)
|
November 14, 2009
How useful is traditional herbal medicine for pulmonary fibrosis?
Jiao Yang, Ye Cui, Martin Kolb
The European Respiratory Journal
|
August 18, 2018
Radiological diagnosis of interstitial lung disease: is it all about pattern recognition?
Simon L F Walsh, Martin Kolb
Chest
|
July 17, 2012
Angiogenesis in pulmonary fibrosis: too much or not enough?
Chandru Hanumegowda, Laszlo Farkas, Martin Kolb
The New England Journal of Medicine
|
May 12, 2021
Inhaled Treprostinil in Group 3 Pulmonary Hypertension
Mouhamad Nasser, Martin Kolb, Vincent Cottin
The European Respiratory Journal
|
April 5, 2020
Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis?
Robert P Dickson, Sergio Harari, Martin Kolb
Page
of 28